Analyst coverage
These analysts follow the development of Cantargia on a regular basis
Carnegie Investment Bank AB
Arvid Necander
REDEYE
Richard Ramanius
Kempen Life Sciences
Sebastiaan van der Schoot
Oppenheimer & Co
Mark Breidenbach and Matthew Biegler
